| AGE | Advanced glycation end product |
| ApoA1 | Apolipoprotein A1 |
| ApoA5 | Apolipoprotein A5 |
| ApoB | Apolipoprotein |
| ApoC3 | Apolipoprotein C3 |
| BLDL-C | Low-density lipoprotein cholesterol |
| BRB | The blood–retina barrier |
| DHA | Docosahexaenoic acid |
| DM | Diabetes mellitus |
| DME | Diabetic macular edema |
| EPA | Eicosapentaenoic acid |
| FGF21 | Fibroblast growth factor 21 |
| HDL-C | High-density lipoprotein cholesterol |
| Lp(a) | Lipoprotein (a) |
| LXRs | liver X receptors |
| MUFAs | Monounsaturated fatty acids |
| NF-Κb | Nuclear Factor-κB |
| NPDR | Nonproliferative diabetic retinopathy |
| Ox-LDL | Oxidized LDL |
| PDR | Proliferative diabetic retinopathy |
| PPARs | Peroxisome proliferator-activated receptors |
| PUFAs | The omega-3 polyunsaturated free acids |
| RPE | Retinal pigment epithelium |
| T1DM | Diabetes mellitus type 1 |
| T2DM | Diabetes mellitus type 2 |
| TG | Triglyceride |
| VLDL-C | Very low-density lipoprotein cholesterol |